For example, it is known that transient activation of JAK/STAT3-signaling is required to trigger cardioprotective effects of MSC-based therapies (Shabbir et al, 2010; Niyaz et al, 2015), but permanent elevation of STAT3 activity is associated with the formation of cancer (Gu et al, 2020). Here, STAT3 is linked to cancer.